Gadoteridol
- Generic Name
- Gadoteridol
- Brand Names
- Prohance
- Drug Type
- Small Molecule
- Chemical Formula
- C17H29GdN4O7
- CAS Number
- 120066-54-8
- Unique Ingredient Identifier
- 0199MV609F
- Background
Gadoteridol provides contrast enhancement of the brain, spine and surrounding tissues resulting in improved visualization (compared with unenhanced MRI) of lesions with abnormal vascularity or those thought to cause a disruption of the normal blood brain barrier. Gadoteridol can also be used for whole body contrast enhanced MRI including the head, neck, live...
- Indication
Gadoteridol is indicated for use with magnetic resonance imaging (MRI) in order to visualize lesions with disrupted blood-brain barrier and/or abnormal vascularity in the brain, spine, and associated tissues in adult and pediatric patients, including term neonates. It is also indicated for visualization of lesions in the head and neck in adult patients.
- Associated Conditions
- Central nervous system lesion, Lesions of the Head and Neck
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.